Systemic anticancer therapy for urothelial carcinoma: UK oncologists’ perspective

MLA

Jones, Robert J., et al. Systemic Anticancer Therapy for Urothelial Carcinoma: UK Oncologists’ Perspective. 2024. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1418823037&authtype=sso&custid=ns315887.

APA

Jones, R. J., Crabb, S. J., Linch, M., Birtle, A. J., McGrane, J., Enting, D., Stevenson, R., Liu, K., Kularatne, B., & Hussain, S. A. (2024). Systemic anticancer therapy for urothelial carcinoma: UK oncologists’ perspective.

Chicago

Jones, Robert J., Simon J. Crabb, Mark Linch, Alison J. Birtle, John McGrane, Deborah Enting, Robert Stevenson, Kin Liu, Bihani Kularatne, and Syed A. Hussain. 2024. “Systemic Anticancer Therapy for Urothelial Carcinoma: UK Oncologists’ Perspective.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1418823037&authtype=sso&custid=ns315887.